Q1 2020 Holdings
Filed 2020-05-15 | 80 holdings | $29.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $8.1M | 239,729 | 27.4% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $6.5M | 853,538 | 22.1% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $3.8M | 33,737 | 13.0% |
| Alector Inc(ALEC) | COM | 014442107 | $3.7M | 155,000 | 12.7% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.3M | 219,800 | 4.5% |
| Accuray Inc(ARAY) | COM | 004397105 | $1.3M | 674,300 | 4.4% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.1M | 184,850 | 3.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $958.0K | 479,051 | 3.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $767.0K | 100,000 | 2.6% |
| Arcturus Therapeutics Hldg I(ARCT) | COM | 03969T109 | $715.0K | 52,586 | 2.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $589.0K | 4,471 | 2.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $386.0K | 27,798 | 1.3% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $41.3K | 13,680,554 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $13.3K | 228,089 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $10.4K | 470,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $9.1K | 46,375 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $9.0K | 33,338 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $7.9K | 72,900 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $7.5K | 179,642 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $6.9K | 80,208 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $6.8K | 1,237,400 | 0.0% |
| Luminex Corp | COM | 55027E102 | $5.6K | 204,091 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $4.9K | 371,033 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $4.7K | 165,306 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $4.4K | 600,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $4.0K | 293,440 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.9K | 346,535 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $3.9K | 747,300 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $3.8K | 1,160,878 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $3.5K | 143,249 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $3.2K | 42,102 | 0.0% |
| Biohaven Pharmaceuticals Hold(BHVN) | COM | G11196105 | $3.1K | 90,600 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $3.1K | 307,541 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $2.8K | $4,000,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $2.7K | 147,714 | 0.0% |
| Axovant Gene Therapies LTD | COM | G0750W203 | $2.5K | 1,021,566 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.3K | 401,619 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COM | 48283N106 | $2.3K | 556,564 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.3K | 60,500 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.1K | 450,900 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.1K | 46,908 | 0.0% |
| Cardiovascular Systems Inc(CSIIEUR) | COM | 141619106 | $1.8K | 51,200 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.8K | 234,952 | 0.0% |
| Affimed NV | COM | N01045108 | $1.8K | 1,133,401 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $1.7K | 147,468 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $1.6K | 105,900 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $1.4K | 54,054 | 0.0% |
| Johnson and Johnson(JNJ) | COM | 478160104 | $1.2K | 9,400 | 0.0% |
| Inogen Inc(INGN) | COM | 45780L104 | $1.2K | 23,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $1.2K | 25,500 | 0.0% |